Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) FCF Payout Ratio (2020 - 2025)

Pharma-Bio Serv (PBSV) has disclosed FCF Payout Ratio for 6 consecutive years, with 7.33 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Payout Ratio changed N/A year-over-year to 7.33, compared with a TTM value of 2.32 through Apr 2025, down 186.82%, and an annual FY2025 reading of 7.76, down 227.48% over the prior year.
  • FCF Payout Ratio was 7.33 for Q3 2025 at Pharma-Bio Serv, down from 5.62 in the prior quarter.
  • Across five years, FCF Payout Ratio topped out at 2.38 in Q1 2024 and bottomed at 7.33 in Q3 2025.
  • Average FCF Payout Ratio over 4 years is 3.37, with a median of 3.83 recorded in 2022.
  • The sharpest move saw FCF Payout Ratio crashed 164.21% in 2022, then plummeted 128.81% in 2025.
  • Year by year, FCF Payout Ratio stood at 1.45 in 2021, then plummeted by 164.21% to 3.83 in 2022, then soared by 35.76% to 2.46 in 2024, then plummeted by 198.44% to 7.33 in 2025.
  • Business Quant data shows FCF Payout Ratio for PBSV at 7.33 in Q3 2025, 5.62 in Q2 2025, and 2.46 in Q2 2024.